Home  Clinical trials Entocort™ (budesonide)
|
|
| Entocort™ (budesonide) Clinical Trial report summaries |
Entocort™ (budesonide) is glucocorticosteroid for inflammatory bowel diseases. It is available as an oral controlled-release formulation of budesonide, Entocort capsules, for the treatment of Crohn's disease, and also as Entocort enema for topical treatment of ulcerative colitis.
Please consult the prescribing information for the country concerned for guidance on the approved use of Entocort™ (budesonide).
| Study Number | Completed Clinical Trial Report Summaries | 08-3039 | Effect of treatment with budesonide CIR capsules and prednisolone on bone density, bone metabolism and osteoporosis in subjects with Crohn’s disease, measured using dual energy X-ray absorptiometry (MATRIX). | BU-008-0005 | A Fixed Versus Flexible Budesonide Dosing Schedule In Crohn’s Disease For The Maintenance Of Remission (FREEDOM) | SD-008-3037 | Efficacy and Safety of Budesonide CIR versus Prednisolone in Children with Active Crohn’s Disease |
|
|
|
|